Measuring the Downstream Impact of 280e Removal
by Erik Ott With a glimmer of light at the end of the tunnel for a move from a Schedule 1 drug to a Schedule 3 drug the cannabis industry has begun to contemplate how the removal of 280e would impact licensed operators. Most of the focus has been on the top publicly-held 12 MSOs and how this benefits their businesses, with many analysts demonstrating free cash flow savings measured in the…
View On WordPress














